Table 3.
HPN-related complications.
| Number of Patients with NETs |
Number of Catheter-Related Bloodstream Infections Reported | Catheter-Related Bloodstream Infection Rate/1000 Catheter Days |
Central Venous Thrombosis | HPN-Related Liver Disease | |
|---|---|---|---|---|---|
| Clement D 2023 [21] | n = 41 | n = 23 | 1/1000 catheter days | NR | NR |
| Sagar V 2020 [22] | n = 8 | n = 4 | 2/1000 catheter days | NR | NR |
| Liu M 2020 [23] | n = 5 | n = 2 | 0.64/1000 catheter days | n = 1 (20%) | n = 1 (20%) |
| Hoda D 2005 ** [24] | n = 5 | n = 18 | 0.97/1000 catheter days | n = 4 (8%) | n = 2 (4%) |
| Nehra V 2001 [25] | n = 1 | NR | NR | NR | NR |
NR: not reported, ** based on entire study cohort (n = 52 patients).